Optimal Balloon Catheter Placement During Sonohysterography
Study Details
Study Description
Brief Summary
Saline infusion sonohysterography and other intrauterine investigations methods may cause uterine cramping, pain and vasovagal reactions. According to few of previous studies the position of catheter placement can affect the magnitude of pain and amount of saline required during the sonohysterography. The purpose of this double blind control trial study is to assess whether the location of the balloon catheter either the uterus or cervix during sonohysterography can affect the magnitude of pain and the rate of vasovagal reaction.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Detailed Description
The proposal of study approved by the investigators institutional review boards and institution's ethical committee, and all participants will sign a written consent before enter to study. A total of 300 infertile women undergoing sonohysterography will be randomized to intrauterine or intracervical balloon catheter placement. The examination is scheduled in the early follicular phase of menstrual cycle, immediately after cessation of menstrual flow and before day 10. After preparation of patient, a 2 lumen 6-French flexible catheter is introduced into the cervical canal and balloon at the catheter tip is placed in the lower uterine segment or 1 cm into cervical canal and inflated with 1 mL of sterile saline solution. Under sonographic guidance, sterile normal saline solution (10-50 mL) is slowly introduced into the cavity until an adequate distention of the uterine cavity is obtained. Three-dimensional ultrasound scanned volumes are recorded. Patients are asked to assess their level of pain at the time of the balloon inflation and deflation using a 10-point visual analog pain scale. Patients are checked for the sign and symptoms of vasovagal reaction during and 30 minutes after procedure. Outcome measures will be assessed based on the intent-to-treat principle.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: patients with intrauterine balloon catheter placement In this group, during the procedure of sonohysterography balloon catheter is inflated in the uterine cavity |
Device: sonohysterography with inflated catheter in uterine cavity
during the procedure of sonohysterography balloon catheter is inflated in the uterine cavity
|
Active Comparator: patients with intracervical balloon catheter placement During the procedure of sonohysterography balloon catheter is inflated in the cervical canal |
Device: sonohysterography with inflated catheter in cervical cavity
During the procedure of sonohysterography balloon catheter is inflated in the cervical canal
|
Outcome Measures
Primary Outcome Measures
- perceived Pain [during sonohysterography]
inflation of the balloon & deflation of the balloon by a 10-point visual analog pain scale
- Vasovagal reactions [During sonohysterography]
Evaluation the vasovagal reactions (Hypotension, vomiting, syncope)in patients During procedure .
- vasovagal reaction [30 minutes after sonohysterography]
Evaluation the vasovagal reactions (Hypotension, vomiting, syncope)in patients 30 minutes after procedure .
Secondary Outcome Measures
- Saline volume [during sonohysterography]
Evaluation the saline volume that is required for sonohisterography
- time of procedure [during sonohysterography]
Evaluation the total time that is needed for sonohysterography.
Eligibility Criteria
Criteria
Inclusion Criteria:
- Infertile patients who will be referred to Royan institute for sonohysterography to evaluate the internal structure of uterine cavity (acquired & congenital abnormalities) are included in this prospective comparative study.
Exclusion Criteria:
-
Exclusion Criteria:
-
Symptoms of active pelvic infection
-
Abnormal uterine bleeding
-
Women with cervical stenosis
-
Women with each lesions which disrupts catheterization such as large myoma
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Royan Institute | Tehran | Iran, Islamic Republic of |
Sponsors and Collaborators
- Royan Institute
Investigators
- Study Chair: Hamid Gourabi, PhD, Head of Royan Institute
- Study Director: Fatemeh Zafarani, MSc, Department of Reproductive Imaging at Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine
- Principal Investigator: Firoozeh Ahmadi, MD, Department of Reproductive Imaging at Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- Royan-Emb-016